News Avadel Pharmaceuticals plc

Equities

AVDL

IE00BDGMC594

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-07 pm EDT			5-day change	1st Jan Change
18.18 ^USD	-2.36%		+0.11%	+31.87%

Apr. 25	European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading	MT
Apr. 23	European Equities Traded in the US as American Depositary Receipts Jump in Tuesday Trading	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 8	May. 01	AQ
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading	Apr. 25	MT
European Equities Traded in the US as American Depositary Receipts Jump in Tuesday Trading	Apr. 23	MT
European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading	Apr. 22	MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	Apr. 17	MT
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading	Apr. 16	MT
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading	Apr. 15	MT
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading	Apr. 11	MT
Avadel Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference	Apr. 01	AQ
European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher in Monday Trading	Mar. 25	MT
European Equities Traded in the US as American Depositary Receipts Ease Wednesday	Mar. 20	MT
Transcript : Avadel Pharmaceuticals plc Presents at UBS Virtual CNS Day 2024, Mar-18-2024 12:30 PM	Mar. 18
Craig-Hallum Adjusts Avadel Pharmaceuticals' Price Target to $22 From $20, Maintains Buy Rating	Mar. 05	MT
HC Wainwright Raises Price Target on Avadel Pharmaceuticals to $25 From $21, Maintains Buy Rating	Mar. 05	MT
Piper Sandler Raises Price Target on Avadel Pharmaceuticals to $23 From $18, Maintains Overweight Rating	Mar. 05	MT
Needham Adjusts Avadel Pharmaceuticals' Price Target to $22 From $20, Keeps Buy Rating	Mar. 05	MT
Oppenheimer Adjusts Avadel Pharmaceuticals Price Target to $29 From $27, Maintains Outperform Rating	Mar. 05	MT
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences	Mar. 05	AQ
ADRs End Higher, Renalytix PLC Climbs 41.4%	Mar. 04	DJ
Avadel Pharmaceuticals Issues Statement On Patent Litigation	Mar. 04	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Avadel Pharmaceuticals plc

Equities

AVDL

IE00BDGMC594

Summary

Filters